| INSIGHT MOLECULAR DIAGNOSTICS |
| USA |
| Gesundheit |
| US68235C2061 / A3EQV9 |
| 7OC0 (Frankfurt) / IMDX (NASDAQ) |
| FRA:7OC0, ETR:7OC0, 7OC0:GR, NASDAQ:IMDX |
| - |
| https://imdxinc.com/ |
|
Insight Molecular Diagnostics Inc. is a molecular diagnostics company focused on precision testing for transplantation and oncology. The company develops and commercializes laboratory-developed, kitted research-use, and clinical diagnostic tests that..
>Volltext.. |
| 63.54 Mio. EUR |
| 49.15 Mio. EUR |
| 1.52 Mio. EUR |
| -31.39 Mio. EUR |
| -44.78 Mio. EUR |
| -1.35 EUR |
| 2.38 Mio. EUR |
| 16.77 Mio. EUR |
| -24.45 Mio. EUR |
| 1.8 |
| -60.77% |
| 22.17% |
| - |
| - |
| - |
| - |
| INSIGHT MOLECULAR |
| 16.11.26 |